{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:24:21Z","timestamp":1788341061073,"version":"build-2803163510"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2020-NR049403"],"award-info":[{"award-number":["RS-2020-NR049403"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A6A1A03046247"],"award-info":[{"award-number":["2022R1A6A1A03046247"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00444468"],"award-info":[{"award-number":["RS-2024-00444468"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00432867"],"award-info":[{"award-number":["RS-2024-00432867"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumour microenvironment (TME) consists of a complex ecosystem of tumour cells, stromal elements, extracellular matrix, fibroblasts and diverse immune-cell populations. Although traditional cancer therapies have primarily focused on eliminating tumour cells, subsequent advances highlighted the importance of modulating immune cells within the TME to enhance anti-tumour immunity. More recently, a major conceptual shift has emerged: targeting nutrient metabolism as a therapeutic strategy. Because tumours create a hypoglycaemic, metabolically restrictive niche, both cancer cells and infiltrating immune cells increasingly rely on lipid uptake, storage and catabolism to sustain their survival and function. This metabolic dependency reveals new vulnerabilities that can be exploited for cancer therapy. In this review, we integrate fundamental concepts of lipid metabolism with recent mechanistic discoveries that define how lipids shape cellular behaviours within the TME, emphasizing the dual roles of lipids as both metabolic substrates and signalling mediators. We also highlight emerging evidence demonstrating that dietary lipid composition \u2014 beyond total fat intake \u2014 profoundly influences tumour progression and anti-tumour immunity. Together, these insights position lipid metabolism as a critical regulator of tumour biology and an attractive target for next-generation cancer therapies.<\/jats:p>","DOI":"10.1038\/s12276-026-01783-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:03:28Z","timestamp":1787036608000},"page":"2562-2575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The interplay between lipid metabolism, cancer progression and anti-cancer immunity"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-6350","authenticated-orcid":false,"given":"Choong-Hyun","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoosun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-4841","authenticated-orcid":false,"given":"Yeonseok","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201606","author":"X Bian","year":"2021","unstructured":"Bian, X. et al. Lipid metabolism and cancer. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20201606 (2021).","journal-title":"J. Exp. Med."},{"key":"1783_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62\u201376 (2020).","journal-title":"Cell Metab."},{"key":"1783_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763\u2013777 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig, F. & Schulze, A. The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer 16, 732\u2013749 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s43018-023-00702-z","volume":"5","author":"FCE Vogel","year":"2024","unstructured":"Vogel, F. C. E., Chaves-Filho, A. B. & Schulze, A. Lipids as mediators of cancer progression and metastasis. Nat. Cancer 5, 16\u201329 (2024).","journal-title":"Nat. Cancer"},{"key":"1783_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang, B., Song, B. L. & Xu, C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat. Metab 2, 132\u2013141 (2020).","journal-title":"Nat. Metab"},{"key":"1783_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nrc3379","volume":"12","author":"JB Park","year":"2012","unstructured":"Park, J. B. et al. Phospholipase signalling networks in cancer. Nat. Rev. Cancer 12, 782\u2013792 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"H-R Jin","year":"2023","unstructured":"Jin, H.-R. et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J. Hematol. Oncol. 16, 103 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"1783_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690\u2013703 (2022).","journal-title":"Nat. Med."},{"key":"1783_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri1936","volume":"6","author":"L Zitvogel","year":"2006","unstructured":"Zitvogel, L., Tesniere, A. & Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6, 715\u2013727 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"1783_CR11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.6065\/apem.2448160.080","volume":"29","author":"J Kim","year":"2024","unstructured":"Kim, J., Lee, Y. & Chung, Y. Control of T-cell immunity by fatty acid metabolism. Ann. Pediatr. Endocrinol. Metab. 29, 356\u2013364 (2024).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"1783_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41568-019-0198-5","volume":"19","author":"EC Lien","year":"2019","unstructured":"Lien, E. C. & Vander Heiden, M. G. A framework for examining how diet impacts tumour metabolism. Nat. Rev. Cancer 19, 651\u2013661 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-020-2124-0","volume":"579","author":"N Kanarek","year":"2020","unstructured":"Kanarek, N., Petrova, B. & Sabatini, D. M. Dietary modifications for enhanced cancer therapy. Nature 579, 507\u2013517 (2020).","journal-title":"Nature"},{"key":"1783_CR14","doi-asserted-by":"publisher","first-page":"e213520","DOI":"10.1001\/jamanetworkopen.2021.3520","volume":"4","author":"F Petrelli","year":"2021","unstructured":"Petrelli, F. et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Network Open 4, e213520\u2013e213520 (2021).","journal-title":"JAMA Network Open"},{"key":"1783_CR15","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2013.08.018","volume":"145","author":"B Philip","year":"2013","unstructured":"Philip, B. et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology 145, 1449\u20131458 (2013).","journal-title":"Gastroenterology"},{"key":"1783_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature13398","volume":"514","author":"MD Schulz","year":"2014","unstructured":"Schulz, M. D. et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514, 508\u2013512 (2014).","journal-title":"Nature"},{"key":"1783_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature17173","volume":"531","author":"S Beyaz","year":"2016","unstructured":"Beyaz, S. et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531, 53\u201358 (2016).","journal-title":"Nature"},{"key":"1783_CR18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191920","author":"T Manzo","year":"2020","unstructured":"Manzo, T. et al. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreative CD8+ T cells. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20191920 (2020).","journal-title":"J. Exp. Med."},{"key":"1783_CR19","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel, A. E. et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 183, 1848\u20131866.e26 (2020).","journal-title":"Cell"},{"key":"1783_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202515186","author":"JE Yian","year":"2025","unstructured":"Yian, J. E. et al. Cancer manipulates adjacent adipose tissue to exploit fatty acids via HIF-1\u03b1\/CCL2\/PPAR\u03b1 axis: a metabolic circuit to support tumor progression. Adv. Sci. https:\/\/doi.org\/10.1002\/advs.202515186 (2025).","journal-title":"Adv. Sci."},{"key":"1783_CR21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s42255-025-01330-w","volume":"7","author":"B Kunkemoeller","year":"2025","unstructured":"Kunkemoeller, B. et al. The source of dietary fat influences anti-tumour immunity in obese mice. Nat. Metab. 7, 1630\u20131645 (2025).","journal-title":"Nat. Metab."},{"key":"1783_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell 32, 377\u2013391.e9 (2017).","journal-title":"Cancer Cell"},{"key":"1783_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng, C., Geng, F., Cheng, X. & Guo, D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun. 38, 27 (2018).","journal-title":"Cancer Commun."},{"key":"1783_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1101\/gad.1987211","volume":"25","author":"K Zaugg","year":"2011","unstructured":"Zaugg, K. et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 25, 1041\u20131051 (2011).","journal-title":"Genes Dev."},{"key":"1783_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio, I. et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 120, 142\u2013156 (2010).","journal-title":"J. Clin. Invest."},{"key":"1783_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","volume":"23","author":"L Poulsen","year":"2012","unstructured":"Poulsen, L., Siersbaek, M. & Mandrup, S. PPARs: fatty acid sensors controlling metabolism. Semin. Cell Dev. Biol. 23, 631\u2013639 (2012).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1783_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-021-00781-x","volume":"19","author":"H Prendeville","year":"2022","unstructured":"Prendeville, H. & Lynch, L. Diet, lipids, and antitumor immunity. Cell. Mol. Immunol. 19, 432\u2013444 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"1783_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","volume":"21","author":"F Pietrocola","year":"2015","unstructured":"Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F. & Kroemer, G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21, 805\u2013821 (2015).","journal-title":"Cell Metab."},{"key":"1783_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2011","unstructured":"Metallo, C. M. et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380\u2013384 (2011).","journal-title":"Nature"},{"key":"1783_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature10642","volume":"481","author":"AR Mullen","year":"2011","unstructured":"Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385\u2013388 (2011).","journal-title":"Nature"},{"key":"1783_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076\u20131080 (2009).","journal-title":"Science"},{"key":"1783_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","volume":"159","author":"SA Comerford","year":"2014","unstructured":"Comerford, S. A. et al. Acetate dependence of tumors. Cell 159, 1591\u20131602 (2014).","journal-title":"Cell"},{"key":"1783_CR33","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"T Mashimo","year":"2014","unstructured":"Mashimo, T. et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159, 1603\u20131614 (2014).","journal-title":"Cell"},{"key":"1783_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","volume":"27","author":"ZT Schug","year":"2015","unstructured":"Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57\u201371 (2015).","journal-title":"Cancer Cell"},{"key":"1783_CR35","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1158\/0008-5472.CAN-05-0571","volume":"65","author":"K Brusselmans","year":"2005","unstructured":"Brusselmans, K., De Schrijver, E., Verhoeven, G. & Swinnen, J. V. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res. 65, 6719\u20136725 (2005).","journal-title":"Cancer Res."},{"key":"1783_CR36","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nm.4181","volume":"22","author":"RU Svensson","year":"2016","unstructured":"Svensson, R. U. et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nat. Med. 22, 1108\u20131119 (2016).","journal-title":"Nat. Med."},{"key":"1783_CR37","first-page":"213","volume":"60","author":"ES Pizer","year":"2000","unstructured":"Pizer, E. S. et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60, 213\u2013218 (2000).","journal-title":"Cancer Res."},{"key":"1783_CR38","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-05-3197","volume":"66","author":"S Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay, S. et al. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res. 66, 5934\u20135940 (2006).","journal-title":"Cancer Res."},{"key":"1783_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro, G. B. et al. Fatty acid synthesis is required for breast cancer brain metastasis. Nat. Cancer 2, 414\u2013428 (2021).","journal-title":"Nat. Cancer"},{"key":"1783_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41586-021-04049-2","volume":"599","author":"EC Lien","year":"2021","unstructured":"Lien, E. C. et al. Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature 599, 302\u2013307 (2021).","journal-title":"Nature"},{"key":"1783_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens, K. et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature 566, 403\u2013406 (2019).","journal-title":"Nature"},{"key":"1783_CR42","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/bjc.2015.371","volume":"113","author":"SH Lim","year":"2015","unstructured":"Lim, S. H. et al. A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI\/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer. Br. J. Cancer 113, 1421\u20131426 (2015).","journal-title":"Br. J. Cancer"},{"key":"1783_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1240","author":"JS Lee","year":"2018","unstructured":"Lee, J. S. et al. Statins enhance efficacy of venetoclax in blood cancers. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaq1240 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1783_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","volume":"567","author":"J Garcia-Bermudez","year":"2019","unstructured":"Garcia-Bermudez, J. et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature 567, 118\u2013122 (2019).","journal-title":"Nature"},{"key":"1783_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/0008-5472.CAN-19-0650","volume":"80","author":"I Kaymak","year":"2020","unstructured":"Kaymak, I. et al. Mevalonate pathway provides ubiquinone to maintain pyrimidine synthesis and survival in p53-deficient cancer cells exposed to metabolic stress. Cancer Res. 80, 189\u2013203 (2020).","journal-title":"Cancer Res."},{"key":"1783_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein, J. L., DeBose-Boyd, R. A. & Brown, M. S. Protein sensors for membrane sterols. Cell 124, 35\u201346 (2006).","journal-title":"Cell"},{"key":"1783_CR47","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev.cellbio.24.110707.175344","volume":"25","author":"A Nohturfft","year":"2009","unstructured":"Nohturfft, A. & Zhang, S. C. Coordination of lipid metabolism in membrane biogenesis. Annu. Rev. Cell Dev. Biol. 25, 539\u2013566 (2009).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1783_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","volume":"23","author":"TI Jeon","year":"2012","unstructured":"Jeon, T. I. & Osborne, T. F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23, 65\u201372 (2012).","journal-title":"Trends Endocrinol. Metab."},{"key":"1783_CR49","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1073\/pnas.1534923100","volume":"100","author":"JD Horton","year":"2003","unstructured":"Horton, J. D. et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl Acad. Sci. USA 100, 12027\u201312032 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1783_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0092-8674(00)00037-4","volume":"102","author":"A Nohturfft","year":"2000","unstructured":"Nohturfft, A., Yabe, D., Goldstein, J. L., Brown, M. S. & Espenshade, P. J. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 102, 315\u2013323 (2000).","journal-title":"Cell"},{"key":"1783_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0092-8674(02)00872-3","volume":"110","author":"T Yang","year":"2002","unstructured":"Yang, T. et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489\u2013500 (2002).","journal-title":"Cell"},{"key":"1783_CR52","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1158\/0008-5472.CAN-2148-2","volume":"64","author":"SL Ettinger","year":"2004","unstructured":"Ettinger, S. L. et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res. 64, 2212\u20132221 (2004).","journal-title":"Cancer Res."},{"key":"1783_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000446","volume":"2","author":"D Guo","year":"2009","unstructured":"Guo, D. et al. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci. Signal. 2, ra82 (2009).","journal-title":"Sci. Signal."},{"key":"1783_CR54","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.3390\/ijms15057124","volume":"15","author":"C Li","year":"2014","unstructured":"Li, C. et al. SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int. J. Mol. Sci. 15, 7124\u20137138 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"1783_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3002-1-3","volume":"1","author":"B Griffiths","year":"2013","unstructured":"Griffiths, B. et al. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab. 1, 3 (2013).","journal-title":"Cancer Metab."},{"key":"1783_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer 122, 4\u201322 (2020).","journal-title":"Br. J. Cancer"},{"key":"1783_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41\u201345 (2017).","journal-title":"Nature"},{"key":"1783_CR58","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","volume":"29","author":"WW Feng","year":"2019","unstructured":"Feng, W. W. et al. CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies. Cell Rep. 29, 3405\u20133420.e5 (2019).","journal-title":"Cell Rep."},{"key":"1783_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5758","author":"MJ Watt","year":"2019","unstructured":"Watt, M. J. et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aau5758 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1783_CR60","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498\u20131503 (2011).","journal-title":"Nat. Med."},{"key":"1783_CR61","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1073\/pnas.1421601112","volume":"112","author":"F Guillaumond","year":"2015","unstructured":"Guillaumond, F. et al. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proc. Natl Acad. Sci. USA 112, 2473\u20132478 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1783_CR62","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/onc.2017.247","volume":"36","author":"EJ Gallagher","year":"2017","unstructured":"Gallagher, E. J. et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene 36, 6462\u20136471 (2017).","journal-title":"Oncogene"},{"key":"1783_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3239-z","volume":"17","author":"T Zhou","year":"2017","unstructured":"Zhou, T. et al. Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC). BMC Cancer 17, 269 (2017).","journal-title":"BMC Cancer"},{"key":"1783_CR64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann, J. A. & Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 20, 137\u2013155 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1783_CR65","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","volume":"24","author":"D Ackerman","year":"2018","unstructured":"Ackerman, D. et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 24, 2596\u20132605.e5 (2018).","journal-title":"Cell Rep."},{"key":"1783_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2020.06.002","volume":"32","author":"X Cheng","year":"2020","unstructured":"Cheng, X. et al. Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress. Cell Metab. 32, 229\u2013242.e8 (2020).","journal-title":"Cell Metab."},{"key":"1783_CR67","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","volume":"19","author":"S Yue","year":"2014","unstructured":"Yue, S. et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 19, 393\u2013406 (2014).","journal-title":"Cell Metab."},{"key":"1783_CR68","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1158\/1078-0432.CCR-15-2973","volume":"22","author":"F Geng","year":"2016","unstructured":"Geng, F. et al. Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clin. Cancer Res. 22, 5337\u20135348 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1783_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02184-z","volume":"10","author":"E Cuyas","year":"2024","unstructured":"Cuyas, E. et al. Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity. Cell Death Discov. 10, 417 (2024).","journal-title":"Cell Death Discov."},{"key":"1783_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115015","volume":"43","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma. Cell Rep. 43, 115015 (2024).","journal-title":"Cell Rep."},{"key":"1783_CR71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378.e6 (2022).","journal-title":"Cancer Cell"},{"key":"1783_CR72","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2015.09.021","volume":"28","author":"C Cheng","year":"2015","unstructured":"Cheng, C. et al. Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth. Cancer Cell 28, 569\u2013581 (2015).","journal-title":"Cancer Cell"},{"key":"1783_CR73","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","volume":"580","author":"D Xu","year":"2020","unstructured":"Xu, D. et al. The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis. Nature 580, 530\u2013535 (2020).","journal-title":"Nature"},{"key":"1783_CR74","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","volume":"20","author":"JV Lee","year":"2014","unstructured":"Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306\u2013319 (2014).","journal-title":"Cell Metab."},{"key":"1783_CR75","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","volume":"9","author":"A Carrer","year":"2019","unstructured":"Carrer, A. et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Discov. 9, 416\u2013435 (2019).","journal-title":"Cancer Discov."},{"key":"1783_CR76","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224\u2013236 (2008).","journal-title":"Cell Metab."},{"key":"1783_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K Duvel","year":"2010","unstructured":"Duvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171\u2013183 (2010).","journal-title":"Mol. Cell"},{"key":"1783_CR78","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1073\/pnas.1705304114","volume":"114","author":"W Eid","year":"2017","unstructured":"Eid, W. et al. mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proc. Natl Acad. Sci. USA 114, 7999\u20138004 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1783_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04664-0","volume":"9","author":"A Talebi","year":"2018","unstructured":"Talebi, A. et al. Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nat. Commun. 9, 2500 (2018).","journal-title":"Nat. Commun."},{"key":"1783_CR80","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ccell.2014.11.024","volume":"27","author":"PA Carroll","year":"2015","unstructured":"Carroll, P. A. et al. Deregulated Myc requires MondoA\/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell 27, 271\u2013285 (2015).","journal-title":"Cancer Cell"},{"key":"1783_CR81","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2019.07.012","volume":"30","author":"AM Gouw","year":"2019","unstructured":"Gouw, A. M. et al. The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth. Cell Metab. 30, 556\u2013572.e5 (2019).","journal-title":"Cell Metab."},{"key":"1783_CR82","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","volume":"176","author":"SH Moon","year":"2019","unstructured":"Moon, S. H. et al. p53 represses the mevalonate pathway to mediate tumor suppression. Cell 176, 564\u2013580.e19 (2019).","journal-title":"Cell"},{"key":"1783_CR83","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376\u2013388 (2011).","journal-title":"Cell Metab."},{"key":"1783_CR84","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","volume":"29","author":"JSV Lally","year":"2019","unstructured":"Lally, J. S. V. et al. Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma. Cell Metab. 29, 174\u2013182.e5 (2019).","journal-title":"Cell Metab."},{"key":"1783_CR85","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon, S. M., Chandel, N. S. & Hay, N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485, 661\u2013665 (2012).","journal-title":"Nature"},{"key":"1783_CR86","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1038\/onc.2015.453","volume":"35","author":"S Morioka","year":"2016","unstructured":"Morioka, S. et al. TAK1 regulates hepatic lipid homeostasis through SREBP. Oncogene 35, 3829\u20133838 (2016).","journal-title":"Oncogene"},{"key":"1783_CR87","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2005.04.010","volume":"1","author":"A Sundqvist","year":"2005","unstructured":"Sundqvist, A. et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7. Cell Metab. 1, 379\u2013391 (2005).","journal-title":"Cell Metab"},{"key":"1783_CR88","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/onc.2015.123","volume":"35","author":"S Li","year":"2016","unstructured":"Li, S., Oh, Y. T., Yue, P., Khuri, F. R. & Sun, S. Y. Inhibition of mTOR complex 2 induces GSK3\/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells. Oncogene 35, 642\u2013650 (2016).","journal-title":"Oncogene"},{"key":"1783_CR89","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/0008-5472.CAN-15-1766","volume":"76","author":"L Liu","year":"2016","unstructured":"Liu, L. et al. Arginine methylation of SREBP1a via PRMT5 promotes de novo lipogenesis and tumor growth. Cancer Res. 76, 1260\u20131272 (2016).","journal-title":"Cancer Res."},{"key":"1783_CR90","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrc3912","volume":"15","author":"CY Lin","year":"2015","unstructured":"Lin, C. Y. & Gustafsson, J. A. Targeting liver X receptors in cancer therapeutics. Nat. Rev. Cancer 15, 216\u2013224 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR91","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","volume":"28","author":"CA Flaveny","year":"2015","unstructured":"Flaveny, C. A. et al. Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis. Cancer Cell 28, 42\u201356 (2015).","journal-title":"Cancer Cell"},{"key":"1783_CR92","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1158\/2159-8290.CD-11-0102","volume":"1","author":"D Guo","year":"2011","unstructured":"Guo, D. et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR\/AKT\/SREBP-1\/LDLR-dependent pathway. Cancer Discov. 1, 442\u2013456 (2011).","journal-title":"Cancer Discov."},{"key":"1783_CR93","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","volume":"30","author":"GR Villa","year":"2016","unstructured":"Villa, G. R. et al. An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers. Cancer Cell 30, 683\u2013693 (2016).","journal-title":"Cancer Cell"},{"key":"1783_CR94","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang, D. & Dubois, R. N. Eicosanoids and cancer. Nat. Rev. Cancer 10, 181\u2013193 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR95","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","volume":"162","author":"S Zelenay","year":"2015","unstructured":"Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257\u20131270 (2015).","journal-title":"Cell"},{"key":"1783_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.178644","author":"N Markosyan","year":"2024","unstructured":"Markosyan, N. et al. Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.178644 (2024).","journal-title":"JCI Insight"},{"key":"1783_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00910-z","volume":"8","author":"AE Baek","year":"2017","unstructured":"Baek, A. E. et al. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat. Commun. 8, 864 (2017).","journal-title":"Nat. Commun."},{"key":"1783_CR98","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma, X. et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab. 30, 143\u2013156.e5 (2019).","journal-title":"Cell Metab."},{"key":"1783_CR99","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/2159-8290.CD-18-1212","volume":"9","author":"FR Auciello","year":"2019","unstructured":"Auciello, F. R. et al. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discov. 9, 617\u2013627 (2019).","journal-title":"Cancer Discov."},{"key":"1783_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.04.018","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. JAK\/STAT3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 27, 1357 (2018).","journal-title":"Cell Metab."},{"key":"1783_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.21","volume":"8","author":"YA Wen","year":"2017","unstructured":"Wen, Y. A. et al. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 8, e2593 (2017).","journal-title":"Cell Death Dis."},{"key":"1783_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye, H. et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell 19, 23\u201337 (2016).","journal-title":"Cell Stem Cell"},{"key":"1783_CR103","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","volume":"36","author":"M Lochner","year":"2015","unstructured":"Lochner, M., Berod, L. & Sparwasser, T. Fatty acid metabolism in the regulation of T cell function. Trends Immunol. 36, 81\u201391 (2015).","journal-title":"Trends Immunol."},{"key":"1783_CR104","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2326-6066.CIR-19-0702","volume":"8","author":"R Lin","year":"2020","unstructured":"Lin, R. et al. Fatty acid oxidation controls CD8+ tissue-resident memory T-cell survival in gastric adenocarcinoma. Cancer Immunol. Res. 8, 479\u2013492 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"1783_CR105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221839","author":"JL Raynor","year":"2024","unstructured":"Raynor, J. L. & Chi, H. Signal 4 in T cell immunity. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20221839 (2024).","journal-title":"J. Exp. Med."},{"key":"1783_CR106","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","volume":"35","author":"CB Nava Lauson","year":"2023","unstructured":"Nava Lauson, C. B. et al. Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity. Cell Metab. 35, 633\u2013650.e9 (2023).","journal-title":"Cell Metab."},{"key":"1783_CR107","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41586-023-06749-3","volume":"623","author":"H Fan","year":"2023","unstructured":"Fan, H. et al. Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity. Nature 623, 1034\u20131043 (2023).","journal-title":"Nature"},{"key":"1783_CR108","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41590-023-01419-y","volume":"24","author":"J Edwards-Hicks","year":"2023","unstructured":"Edwards-Hicks, J. et al. Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and function. Nat. Immunol. 24, 516\u2013530 (2023).","journal-title":"Nat. Immunol."},{"key":"1783_CR109","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.immuni.2023.07.002","volume":"56","author":"KM Luda","year":"2023","unstructured":"Luda, K. M. et al. Ketolysis drives CD8+ T cell effector function through effects on histone acetylation. Immunity 56, 2021\u20132035.e8 (2023).","journal-title":"Immunity"},{"key":"1783_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis, N. et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6, 6692 (2015).","journal-title":"Nat. Commun."},{"key":"1783_CR111","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","volume":"31","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab. 31, 148\u2013161.e5 (2020).","journal-title":"Cell Metab."},{"key":"1783_CR112","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.20171576","volume":"215","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity. J. Exp. Med. 215, 1555\u20131569 (2018).","journal-title":"J. Exp. Med."},{"key":"1783_CR113","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1126\/science.adl4100","volume":"387","author":"SK Varanasi","year":"2025","unstructured":"Varanasi, S. K. et al. Bile acid synthesis impedes tumor-specific T cell responses during liver cancer. Science 387, 192\u2013201 (2025).","journal-title":"Science"},{"key":"1783_CR114","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang, W. et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature 531, 651\u2013655 (2016).","journal-title":"Nature"},{"key":"1783_CR115","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561\u20131577.e7 (2021).","journal-title":"Immunity"},{"key":"1783_CR116","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012.e5 (2021).","journal-title":"Cell Metab."},{"key":"1783_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53706-3","volume":"15","author":"S Punyawatthananukool","year":"2024","unstructured":"Punyawatthananukool, S. et al. Prostaglandin E2-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells. Nat. Commun. 15, 9464 (2024).","journal-title":"Nat. Commun."},{"key":"1783_CR118","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210042","author":"L Dyck","year":"2022","unstructured":"Dyck, L. et al. Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20210042 (2022).","journal-title":"J. Exp. Med."},{"key":"1783_CR119","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adr4795","volume":"10","author":"K Slattery","year":"2025","unstructured":"Slattery, K. et al. Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer. Sci. Immunol. 10, eadr4795 (2025).","journal-title":"Sci. Immunol."},{"key":"1783_CR120","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet, X. et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat. Immunol. 19, 1330\u20131340 (2018).","journal-title":"Nat. Immunol."},{"key":"1783_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6045-y","volume":"19","author":"SR Niavarani","year":"2019","unstructured":"Niavarani, S. R. et al. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period. BMC Cancer 19, 823 (2019).","journal-title":"BMC Cancer"},{"key":"1783_CR122","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41590-024-01811-2","volume":"25","author":"JH Li","year":"2024","unstructured":"Li, J. H. et al. MEF2C regulates NK cell effector functions through control of lipid metabolism. Nat. Immunol. 25, 778\u2013789 (2024).","journal-title":"Nat. Immunol."},{"key":"1783_CR123","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood.2020005602","volume":"136","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood 136, 3004\u20133017 (2020).","journal-title":"Blood"},{"key":"1783_CR124","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"key":"1783_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 35, 109235 (2021).","journal-title":"Cell Rep."},{"key":"1783_CR126","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai, S. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell 40, 201\u2013218.e9 (2022).","journal-title":"Cancer Cell"},{"key":"1783_CR127","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","volume":"591","author":"SA Lim","year":"2021","unstructured":"Lim, S. A. et al. Lipid signalling enforces functional specialization of Treg cells in tumours. Nature 591, 306\u2013311 (2021).","journal-title":"Nature"},{"key":"1783_CR128","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41590-022-01373-1","volume":"24","author":"MJ Kim","year":"2023","unstructured":"Kim, M. J. et al. Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells. Nat. Immunol. 24, 148\u2013161 (2023).","journal-title":"Nat. Immunol."},{"key":"1783_CR129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138519","author":"SL Pompura","year":"2021","unstructured":"Pompura, S. L. et al. Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI138519 (2021).","journal-title":"J. Clin. Invest."},{"key":"1783_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac, C. et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat. Commun. 11, 2168 (2020).","journal-title":"Nat. Commun."},{"key":"1783_CR131","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"1783_CR132","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1002\/1873-3468.12771","volume":"591","author":"K Rabold","year":"2017","unstructured":"Rabold, K., Netea, M. G., Adema, G. J. & Netea-Maier, R. T. Cellular metabolism of tumor-associated macrophages \u2014 functional impact and consequences. FEBS Lett. 591, 3022\u20133041 (2017).","journal-title":"FEBS Lett."},{"key":"1783_CR133","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cellimm.2018.01.009","volume":"330","author":"J Van den Bossche","year":"2018","unstructured":"Van den Bossche, J. & Saraber, D. L. Metabolic regulation of macrophages in tissues. Cell Immunol. 330, 54\u201359 (2018).","journal-title":"Cell Immunol."},{"key":"1783_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215224","author":"S Kumar","year":"2022","unstructured":"Kumar, S. et al. Metabolic reprogramming in tumor-associated macrophages in the ovarian tumor microenvironment. Cancers https:\/\/doi.org\/10.3390\/cancers14215224 (2022).","journal-title":"Cancers"},{"key":"1783_CR135","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/JLB.1A0521-251R","volume":"112","author":"MM Albakri","year":"2022","unstructured":"Albakri, M. M., Huang, S. C., Tashkandi, H. N. & Sieg, S. F. Fatty acids secreted from head and neck cancer induce M2-like macrophages. J. Leukoc. Biol. 112, 617\u2013628 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"1783_CR136","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41391-021-00440-2","volume":"25","author":"P Liang","year":"2022","unstructured":"Liang, P. et al. Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120. Prostate Cancer Prostatic Dis. 25, 539\u2013546 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1783_CR137","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","volume":"80","author":"P Su","year":"2020","unstructured":"Su, P. et al. Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res. 80, 1438\u20131450 (2020).","journal-title":"Cancer Res."},{"key":"1783_CR138","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.101221","volume":"13","author":"M Yorek","year":"2024","unstructured":"Yorek, M. et al. FABP4-mediated lipid accumulation and lipolysis in tumor-associated macrophages promote breast cancer metastasis. eLife 13, RP101221 (2024).","journal-title":"eLife"},{"key":"1783_CR139","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1158\/0008-5472.CAN-17-2465","volume":"78","author":"J Hao","year":"2018","unstructured":"Hao, J. et al. Expression of adipocyte\/macrophage fatty acid-binding protein in tumor-associated macrophages promotes breast cancer progression. Cancer Res. 78, 2343\u20132355 (2018).","journal-title":"Cancer Res."},{"key":"1783_CR140","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210564","author":"M Masetti","year":"2021","unstructured":"Masetti, M. et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20210564 (2021).","journal-title":"J. Exp. Med."},{"key":"1783_CR141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2017.12.011","volume":"94","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Fatty acid oxidation contributes to IL-1\u03b2 secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration. Mol. Immunol. 94, 27\u201335 (2018).","journal-title":"Mol. Immunol."},{"key":"1783_CR142","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/2326-6066.CIR-19-0261","volume":"8","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis. Cancer Immunol. Res. 8, 710\u2013721 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"1783_CR143","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.7150\/ijbs.117909","volume":"21","author":"J Chang","year":"2025","unstructured":"Chang, J. et al. DPP7 promotes fatty acid \u03b2-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer. Int. J. Biol. Sci. 21, 6305\u20136325 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"1783_CR144","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910698","volume":"11","author":"H Wu","year":"2019","unstructured":"Wu, H. et al. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. EMBO Mol. Med. 11, e10698 (2019).","journal-title":"EMBO Mol. Med."},{"key":"1783_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07685-9","volume":"7","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells. Sci. Rep. 7, 7498 (2017).","journal-title":"Sci. Rep."},{"key":"1783_CR146","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1101\/gad.312355.118","volume":"32","author":"VL Nelson","year":"2018","unstructured":"Nelson, V. L. et al. PPAR\u03b3 is a nexus controlling alternative activation of macrophages via glutamine metabolism. Genes Dev. 32, 1035\u20131044 (2018).","journal-title":"Genes Dev."},{"key":"1783_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00523-6","volume":"8","author":"Z Niu","year":"2017","unstructured":"Niu, Z. et al. Caspase-1 cleaves PPAR\u03b3 for potentiating the pro-tumor action of TAMs. Nat. Commun. 8, 766 (2017).","journal-title":"Nat. Commun."},{"key":"1783_CR148","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","volume":"7","author":"JI Odegaard","year":"2008","unstructured":"Odegaard, J. I. et al. Alternative M2 activation of Kupffer cells by PPAR\u03b4 ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496\u2013507 (2008).","journal-title":"Cell Metab."},{"key":"1783_CR149","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/01635589009514056","volume":"13","author":"JB Lasekan","year":"1990","unstructured":"Lasekan, J. B., Clayton, M. K., Gendron-Fitzpatrick, A. & Ney, D. M. Dietary olive and safflower oils in promotion of DMBA-induced mammary tumorigenesis in rats. Nutr. Cancer 13, 153\u2013163 (1990).","journal-title":"Nutr. Cancer"},{"key":"1783_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/nu11123012","volume":"11","author":"WJ Turbitt","year":"2019","unstructured":"Turbitt, W. J., Collins, S. D., Meng, H. & Rogers, C. J. Increased adiposity enhances the accumulation of MDSCs in the tumor microenvironment and adipose tissue of pancreatic tumor-bearing mice and in immune organs of tumor-free hosts. Nutrients 11, 3012 (2019).","journal-title":"Nutrients"},{"key":"1783_CR151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306776121","volume":"121","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. Proc. Natl Acad. Sci. USA 121, e2306776121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1783_CR152","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2119\/molmed.2011.00311","volume":"18","author":"S Issazadeh-Navikas","year":"2012","unstructured":"Issazadeh-Navikas, S., Teimer, R. & Bockermann, R. Influence of dietary components on regulatory T cells. Mol. Med. 18, 95\u2013110 (2012).","journal-title":"Mol. Med."},{"key":"1783_CR153","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","volume":"630","author":"JE Bader","year":"2024","unstructured":"Bader, J. E. et al. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature 630, 968\u2013975 (2024).","journal-title":"Nature"},{"key":"1783_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13997","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat. Commun. 8, 13997 (2017).","journal-title":"Nat. Commun."},{"key":"1783_CR155","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00011-019-01273-5","volume":"68","author":"J Korbecki","year":"2019","unstructured":"Korbecki, J. & Bajdak-Rusinek, K. The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms. Inflamm. Res. 68, 915\u2013932 (2019).","journal-title":"Inflamm. Res."},{"key":"1783_CR156","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/carcin\/bgy141","volume":"40","author":"KB Pedersen","year":"2019","unstructured":"Pedersen, K. B. et al. Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus. Carcinogenesis 40, 349\u2013359 (2019).","journal-title":"Carcinogenesis"},{"key":"1783_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12298-z","volume":"10","author":"DP Labb\u00e9","year":"2019","unstructured":"Labb\u00e9, D. P. et al. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program. Nat. Commun. 10, 4358 (2019).","journal-title":"Nat. Commun."},{"key":"1783_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216511","volume":"581","author":"S Sun","year":"2024","unstructured":"Sun, S. et al. PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt\/mTOR-mediated Ca2+ flux. Cancer Lett. 581, 216511 (2024).","journal-title":"Cancer Lett."},{"key":"1783_CR159","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11745-002-0961-8","volume":"37","author":"T Yamaki","year":"2002","unstructured":"Yamaki, T. et al. High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal-regulated kinase cascade. Lipids 37, 783\u2013788 (2002).","journal-title":"Lipids"},{"key":"1783_CR160","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-21-0757","volume":"81","author":"R Jin","year":"2021","unstructured":"Jin, R. et al. Dietary fats high in linoleic acids impair antitumor T-cell responses by inducing E-FABP-mediated mitochondrial dysfunction. Cancer Res. 81, 5296\u20135310 (2021).","journal-title":"Cancer Res."},{"key":"1783_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2025.102687","volume":"206","author":"M Sanchez-Juarez","year":"2025","unstructured":"Sanchez-Juarez, M. et al. Linoleic acid promotes mammary tumor growth and metastasis to brain and lung in female Balb\/cJ mice. Prostaglandins Leukot. Essent. Fatty Acids 206, 102687 (2025).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"1783_CR162","doi-asserted-by":"publisher","DOI":"10.1126\/science.adm9805","volume":"387","author":"N Koundouros","year":"2025","unstructured":"Koundouros, N. et al. Direct sensing of dietary \u03c9-6 linoleic acid through FABP5-mTORC1 signaling. Science 387, eadm9805 (2025).","journal-title":"Science"},{"key":"1783_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-025-00367-w","volume":"15","author":"N Atashi","year":"2025","unstructured":"Atashi, N. et al. Dietary intake and tissue biomarkers of omega-6 fatty acids and risk of colorectal cancer in adults: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutr. Diabetes 15, 17 (2025).","journal-title":"Nutr. Diabetes"},{"key":"1783_CR164","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/01635580701499537","volume":"59","author":"Y Kimura","year":"2007","unstructured":"Kimura, Y. & Sumiyoshi, M. High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice. Nutr. Cancer 59, 207\u2013216 (2007).","journal-title":"Nutr. Cancer"},{"key":"1783_CR165","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","volume":"178","author":"G Llaverias","year":"2011","unstructured":"Llaverias, G. et al. Role of cholesterol in the development and progression of breast cancer. Am. J. Pathol. 178, 402\u2013412 (2011).","journal-title":"Am. J. Pathol."},{"key":"1783_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59845-3","volume":"14","author":"A Magalh\u00e3es","year":"2024","unstructured":"Magalh\u00e3es, A. et al. A high-cholesterol diet promotes the intravasation of breast tumor cells through an LDL\u2013LDLR axis. Sci. Rep. 14, 9471 (2024).","journal-title":"Sci. Rep."},{"key":"1783_CR167","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","volume":"29","author":"P Goossens","year":"2019","unstructured":"Goossens, P. et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 29, 1376\u20131389.e4 (2019).","journal-title":"Cell Metab."},{"key":"1783_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.722450","volume":"8","author":"P Miao","year":"2021","unstructured":"Miao, P. & Guan, L. Association of dietary cholesterol intake with risk of gastric cancer: a systematic review and meta-analysis of observational studies. Front. Nutr. 8, 722450 (2021).","journal-title":"Front. Nutr."},{"key":"1783_CR169","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/annonc\/mdr155","volume":"23","author":"J Hu","year":"2012","unstructured":"Hu, J. et al. Dietary cholesterol intake and cancer. Ann. Oncol. 23, 491\u2013500 (2012).","journal-title":"Ann. Oncol."},{"key":"1783_CR170","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/jnci\/85.21.1743","volume":"85","author":"DP Rose","year":"1993","unstructured":"Rose, D. P. & Connolly, J. M. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice. J. Natl Cancer Inst. 85, 1743\u20131747 (1993).","journal-title":"J. Natl Cancer Inst."},{"key":"1783_CR171","first-page":"16","volume":"38","author":"E Damasco-Avila","year":"2018","unstructured":"Damasco-Avila, E., Gallegos, J. L., Guevara, M. & Zentella, A. Omega-3 polyunsaturated fatty acids supplemented diet and its preventive effect on tumor growth in nude mice. Nutr. Clin. Diet. Hosp. 38, 16\u201321 (2018).","journal-title":"Nutr. Clin. Diet. Hosp."},{"key":"1783_CR172","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1038\/onc.2014.283","volume":"34","author":"H Chung","year":"2015","unstructured":"Chung, H. et al. Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer. Oncogene 34, 3504\u20133513 (2015).","journal-title":"Oncogene"},{"key":"1783_CR173","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0304-3835(02)00432-9","volume":"187","author":"T Kato","year":"2002","unstructured":"Kato, T. et al. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett. 187, 169\u2013177 (2002).","journal-title":"Cancer Lett."},{"key":"1783_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030485","author":"M Notarnicola","year":"2017","unstructured":"Notarnicola, M. et al. Dietary \u03c9-3 polyunsaturated fatty acids inhibit tumor growth in transgenic ApcMin\/+ mice, correlating with CB1 receptor up-regulation. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms18030485 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1783_CR175","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1158\/0008-5472.CAN-19-3184","volume":"80","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Consumption of the fish oil high-fat diet uncouples obesity and mammary tumor growth through induction of reactive oxygen species in protumor macrophages. Cancer Res. 80, 2564\u20132574 (2020).","journal-title":"Cancer Res."},{"key":"1783_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106096","volume":"115","author":"ALA Souza","year":"2024","unstructured":"Souza, A. L. A. et al. Omega-3 fatty acid supplementation attenuates intestinal mucositis and tumor growth in a murine model of breast cancer. J. Funct. Foods 115, 106096 (2024).","journal-title":"J. Funct. Foods"},{"key":"1783_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01193-y","volume":"5","author":"P Harre","year":"2025","unstructured":"Harre, P. et al. Dietary \u03c9\u22123 polyunsaturated fatty acids (PUFAs) reduce cholesterol-driven non-small cell lung cancer (NSCLC) progression in mouse models of disease. Commun. Med. 5, 432 (2025).","journal-title":"Commun. Med."},{"key":"1783_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-5-12","volume":"5","author":"WE Hardman","year":"2005","unstructured":"Hardman, W. E., Sun, L., Short, N. & Cameron, I. L. Dietary omega-3 fatty acids and ionizing irradiation on human breast cancer xenograft growth and angiogenesis. Cancer Cell Int. 5, 12 (2005).","journal-title":"Cancer Cell Int."},{"key":"1783_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0529-z","volume":"16","author":"J Li","year":"2017","unstructured":"Li, J. et al. Dietary supplementation of \u03b1-linolenic acid induced conversion of n-3 LCPUFAs and reduced prostate cancer growth in a mouse model. Lipids Health Dis. 16, 136 (2017).","journal-title":"Lipids Health Dis."},{"key":"1783_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106157","volume":"116","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Dietary supplementation of \u03b1-linolenic acid-rich flaxseed oil enhances anti-PD-1 protection against orthotopic hepatocellular carcinoma by reshaping gut homeostasis and improving anti-tumor immunity via gut-liver axis in mice. J. Funct. Foods 116, 106157 (2024).","journal-title":"J. Funct. Foods"},{"key":"1783_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.948604","volume":"9","author":"ZB Dai","year":"2022","unstructured":"Dai, Z. B. et al. Association of dietary intake and biomarker of alpha-linolenic acid with incident colorectal cancer: a dose-response meta-analysis of prospective cohort studies. Front. Nutr. 9, 948604 (2022).","journal-title":"Front. Nutr."},{"key":"1783_CR182","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1001\/jamainternmed.2015.4838","volume":"175","author":"E Toledo","year":"2015","unstructured":"Toledo, E. et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED Trial: a randomized clinical trial. JAMA Intern. Med. 175, 1752\u20131760 (2015).","journal-title":"JAMA Intern. Med."},{"key":"1783_CR183","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10585-010-9340-1","volume":"27","author":"A Soto-Guzman","year":"2010","unstructured":"Soto-Guzman, A., Navarro-Tito, N., Castro-Sanchez, L., Martinez-Orozco, R. & Salazar, E. P. Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin. Exp. Metastasis 27, 505\u2013515 (2010).","journal-title":"Clin. Exp. Metastasis"},{"key":"1783_CR184","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2018.09.006","volume":"438","author":"P Yang","year":"2018","unstructured":"Yang, P. et al. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src\/ERK pathway. Cancer Lett. 438, 76\u201385 (2018).","journal-title":"Cancer Lett."},{"key":"1783_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1023-6","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways. Lipids Health Dis. 18, 76 (2019).","journal-title":"Lipids Health Dis."},{"key":"1783_CR186","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg6453","volume":"9","author":"S Bagchi","year":"2024","unstructured":"Bagchi, S. et al. The acid-sensing receptor GPR65 on tumor macrophages drives tumor growth in obesity. Sci. Immunol. 9, eadg6453. https:\/\/doi.org\/10.1126\/sciimmunol.adg6453 (2024).","journal-title":"Sci. Immunol."},{"key":"1783_CR187","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jnci\/89.7.488","volume":"89","author":"NF Boyd","year":"1997","unstructured":"Boyd, N. F. et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J. Natl Cancer Inst. 89, 488\u2013496 (1997).","journal-title":"J. Natl Cancer Inst."},{"key":"1783_CR188","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.295.6.629","volume":"295","author":"RL Prentice","year":"2006","unstructured":"Prentice, R. L. et al. Low-fat dietary pattern and risk of invasive breast cancer. The Women\u2019s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295, 629\u2013642 (2006).","journal-title":"JAMA"},{"key":"1783_CR189","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/jn\/nxz107","volume":"149","author":"RL Prentice","year":"2019","unstructured":"Prentice, R. L. et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. J. Nutr. 149, 1565\u20131574 (2019).","journal-title":"J. Nutr."},{"key":"1783_CR190","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.19.00435","volume":"38","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski, R. T. et al. Dietary modification and breast cancer mortality: long-term follow-up of the Women\u2019s Health Initiative Randomized Trial. J. Clin. Oncol. 38, 1419\u20131428 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1783_CR191","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky065","volume":"2","author":"RT Chlebowski","year":"2018","unstructured":"Chlebowski, R. T. et al. Low-fat dietary pattern and cancer mortality in the Women\u2019s Health Initiative (WHI) Randomized Controlled Trial. JNCI Cancer Spectr. 2, pky065 (2018).","journal-title":"JNCI Cancer Spectr."},{"key":"1783_CR192","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz005","volume":"3","author":"LJ Peppone","year":"2019","unstructured":"Peppone, L. J. et al. Multicenter randomized controlled trial of omega-3 fatty acids versus omega-6 fatty acids for the control of cancer-related fatigue among breast cancer survivors. JNCI Cancer Spectr. 3, pkz005 (2019).","journal-title":"JNCI Cancer Spectr."},{"key":"1783_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06336-2","volume":"23","author":"R Sadeghi","year":"2025","unstructured":"Sadeghi, R. et al. Dietary and circulating omega-6 fatty acids and their impact on cardiovascular disease, cancer risk, and mortality: a global meta-analysis of 150 cohorts and meta-regression. J. Transl. Med. 23, 314 (2025).","journal-title":"J. Transl. Med."},{"key":"1783_CR194","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.90132","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Higher ratio of plasma omega-6\/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: a population-based cohort study in UK Biobank. eLife 12, RP90132 (2024).","journal-title":"eLife"},{"key":"1783_CR195","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2021.11.023","volume":"526","author":"L Wei","year":"2022","unstructured":"Wei, L., Wu, Z. & Chen, Y. Q. Multi-targeted therapy of cancer by omega-3 fatty acids-an update. Cancer Lett. 526, 193\u2013204 (2022).","journal-title":"Cancer Lett."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01783-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01783-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01783-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:03:46Z","timestamp":1788339826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01783-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":195,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01783-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}